DNLI
Price
$14.55
Change
-$0.38 (-2.55%)
Updated
Jun 13 closing price
Capitalization
2.11B
47 days until earnings call
MLTX
Price
$44.21
Change
+$0.19 (+0.43%)
Updated
Jun 13 closing price
Capitalization
2.81B
54 days until earnings call
Interact to see
Advertisement

DNLI vs MLTX

Header iconDNLI vs MLTX Comparison
Open Charts DNLI vs MLTXBanner chart's image
Denali Therapeutics
Price$14.55
Change-$0.38 (-2.55%)
Volume$2M
Capitalization2.11B
MoonLake Immunotherapeutics
Price$44.21
Change+$0.19 (+0.43%)
Volume$316.29K
Capitalization2.81B
DNLI vs MLTX Comparison Chart
Loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DNLI vs. MLTX commentary
Jun 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLI is a StrongBuy and MLTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 14, 2025
Stock price -- (DNLI: $14.55 vs. MLTX: $44.21)
Brand notoriety: DNLI and MLTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNLI: 138% vs. MLTX: 59%
Market capitalization -- DNLI: $2.11B vs. MLTX: $2.81B
DNLI [@Biotechnology] is valued at $2.11B. MLTX’s [@Biotechnology] market capitalization is $2.81B. The market cap for tickers in the [@Biotechnology] industry ranges from $355.9B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNLI’s FA Score shows that 0 FA rating(s) are green whileMLTX’s FA Score has 0 green FA rating(s).

  • DNLI’s FA Score: 0 green, 5 red.
  • MLTX’s FA Score: 0 green, 5 red.
According to our system of comparison, both DNLI and MLTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNLI’s TA Score shows that 5 TA indicator(s) are bullish while MLTX’s TA Score has 6 bullish TA indicator(s).

  • DNLI’s TA Score: 5 bullish, 4 bearish.
  • MLTX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, MLTX is a better buy in the short-term than DNLI.

Price Growth

DNLI (@Biotechnology) experienced а -1.02% price change this week, while MLTX (@Biotechnology) price change was -5.70% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.75%. For the same industry, the average monthly price growth was +12.94%, and the average quarterly price growth was +4.02%.

Reported Earning Dates

DNLI is expected to report earnings on Jul 31, 2025.

MLTX is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (-0.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLTX($2.81B) has a higher market cap than DNLI($2.11B). MLTX YTD gains are higher at: -18.356 vs. DNLI (-28.606). MLTX has higher annual earnings (EBITDA): -141.71M vs. DNLI (-505.16M). DNLI has more cash in the bank: 818M vs. MLTX (448M). MLTX has less debt than DNLI: MLTX (2.83M) vs DNLI (48.6M). DNLI (0) and MLTX (0) have equivalent revenues.
DNLIMLTXDNLI / MLTX
Capitalization2.11B2.81B75%
EBITDA-505.16M-141.71M356%
Gain YTD-28.606-18.356156%
P/E RatioN/AN/A-
Revenue00-
Total Cash818M448M183%
Total Debt48.6M2.83M1,717%
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
60
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
40
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DNLIMLTX
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
75%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
67%
Momentum
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
64%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
64%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
59%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
76%
Advances
ODDS (%)
Bullish Trend 25 days ago
78%
Bullish Trend 10 days ago
81%
Declines
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 2 days ago
74%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
64%
Aroon
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JLGRX84.85N/A
N/A
JPMorgan Large Cap Growth R5
FACSX49.80N/A
N/A
Nuveen Mid Cap Value 1 C
PJARX10.11N/A
N/A
Principal SmallCap Value II R3
BEXUX17.41N/A
N/A
Baron Emerging Markets R6
BRKCX15.27-0.21
-1.36%
MFS Blended Research Em Mkts Eq C

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been loosely correlated with XENE. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if MLTX jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
+0.43%
XENE - MLTX
45%
Loosely correlated
-0.12%
XNCR - MLTX
45%
Loosely correlated
-2.55%
IDYA - MLTX
43%
Loosely correlated
-0.45%
CLDX - MLTX
42%
Loosely correlated
+4.47%
CRNX - MLTX
42%
Loosely correlated
-1.24%
More